Researchers present an overview of treatment and management strategies for patients with HR+/HER2+ breast cancer, including common adverse effects.
Researchers recommend that future studies examine potential associations between survival and genomic mutations, clinical treatment history, and area deprivation index.
Zohran Mamdani’s campaign platform outlined an ambitious plan to expand access to health care and strengthen New York City’s public health infrastructure.
Researchers evaluated trends in hepatitis C virus testing, diagnosis, and treatment across the US from 2014 to 2021.
Using real-world data, researchers evaluated the safety and effectiveness of fecal microbiota, live-jslm in preventing recurrent Clostridioides difficile infection.
The risk of lung cancer varies among responders involved in rescue and recovery after the collapse of the World Trade Center, a study suggests.
Distinctive reproductive and metabolic trajectories were seen on prospective follow-up and with in vitro fertilization treatment data.
Dr George Tidmarsh, who joined the FDA in July, stepped down Sunday, The New York Times reported. His resignation came just days after he was placed on administrative leave while federal officials ...
HealthDay News — The incidence of alpha-gal syndrome (AGS), typically linked to bites from the lone star tick, increased considerably from 2013-2014 to 2021-2022, according to a study presented at the ...
In light of Serena Williams’s endorsement of GLP-1 medications, we interviewed an obesity medicine specialist about the implications of these medications for professional athletes.
Interviews with patients revealed that sexual health discussions are a vital part of overall cancer care for women with gynecologic cancers.
Developers of biosimilars -- medicines that are near-identical copies of biologic drugs -- will no longer be required to conduct clinical trials to prove effectiveness.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results